title: Schedule-dependent efficacy of camptothecins in models of human cancer.
authors.affiliation: Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101, USA.
authors.forename: P J
authors.initials: PJ
authors.lastname: Houghton
authors.forename: C F
authors.initials: CF
authors.lastname: Stewart
authors.forename: W C
authors.initials: WC
authors.lastname: Zamboni
authors.forename: J
authors.initials: J
authors.lastname: Thompson
authors.forename: X
authors.initials: X
authors.lastname: Luo
authors.forename: M K
authors.initials: MK
authors.lastname: Danks
authors.forename: J A
authors.initials: JA
authors.lastname: Houghton
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000627:therapeutic use / Q000633:toxicity; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use / Q000633:toxicity; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004791:Enzyme Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000077146:Irinotecan; D051379:Mice; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D059004:Topoisomerase I Inhibitors; D019772:Topotecan; D014407:Tumor Cells, Cultured
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D004791:Enzyme Inhibitors; D059004:Topoisomerase I Inhibitors; D000077146:Irinotecan; D019772:Topotecan; D002166:Camptothecin